Real-World Switch Rates of Biologics and Associated Costs in Patients With Psoriasis

被引:0
|
作者
Wu, Jashin J. [1 ]
Patel, Manish [2 ]
Li, Chao [2 ]
Garg, Vishvas [2 ]
Mandava, Monika Rao [2 ]
Armstrong, April W. [3 ]
机构
[1] Univ Miami, Dept Dermatol, Miller Sch Med, Coral Gables, FL USA
[2] AbbVie Inc, N Chicago, IL USA
[3] Univ Southern Calif, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
41279
引用
收藏
页码:AB81 / AB81
页数:1
相关论文
共 50 条
  • [31] Real-world drug survival and reasons for treatment discontinuation of biologics and apremilast in patients with psoriasis in an academic center
    Zeb, Lawangeen
    Mhaskar, Rahul
    Lewis, Suzanna
    Patel, Nishit S.
    Sadhwani, Divya
    Patel, Nupur
    Ekhlassi, Erfon
    Lu, Yuanyuan
    Seminario-Vidal, Lucia
    DERMATOLOGIC THERAPY, 2021, 34 (02)
  • [32] Resource utilization and costs associated with adalimumab or etanercept for moderate to severe psoriasis in a real-world setting
    Papp, Kim
    Guerin, Annie
    Gupta, Shiraz
    Bao, Yanjun
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB159 - AB159
  • [33] Assessment of Real-World Escalation to Biologics in US Patients With Asthma
    Bender, Bruce
    Oppenheimer, John
    George, Maureen
    Brown, Randall
    Patel, Ayush
    Hill, Tanisha
    Boe, Amanda
    Herrera, Ernesto Mayen
    Dotiwala, Zenobia
    Casciano, Julian
    Bernstein, Jonathan A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (11): : 2941 - 2948
  • [34] Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
    Pei-Tzu Lin
    Shu-Hui Wang
    Ching-Chi Chi
    Scientific Reports, 8
  • [35] Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
    Lin, Pei-Tzu
    Wang, Shu-Hui
    Chi, Ching-Chi
    SCIENTIFIC REPORTS, 2018, 8
  • [36] Real-world dose escalation of biologics for moderate-to-severe psoriasis in the United States
    Wu, Jashin J.
    Patel, Manish
    Zeng, Feng
    Huang, Ahong
    Pan, Xing
    Cao, Yiwen
    Chen, Naijun
    Photowala, Huzefa
    Garg, Vishvas
    Crowley, Jeff
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [37] A real-world retrospective study on biologics utilization in patients with psoriasis in Greece during the period 2015-2020
    Lazaridou, E.
    Kourlaba, G.
    Lampropoulou, D. I.
    Gounelas, G.
    Tsolakidis, A.
    Mathioudakis, K.
    Apalla, Z.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (07)
  • [38] Real-world reasons for discontinuation of biologics and apremilast in patients with psoriasis: The University of South Florida Dermatology clinic experience
    Zeb, Lawangeen
    Lewis, Suzanna
    Patel, Nishit
    Sadhwani, Divya
    Patel, Nupur
    Ekhlassi, Erfon
    Lu, Yuanyuan
    Choi, Hyunji
    Schmitt, Amanda
    Seminario-Vidal, Lucia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB116 - AB116
  • [39] Drug survival of biologics in patients with psoriasis: real-world evidence for Greece during the period 2016-2020
    Lazaridou, Elizabeth
    Kourlaba, Georgia
    Ravanidis, Stylianos
    Gounelas, George
    Stefanou, Garyfallia
    Tsolakidis, Anastasios
    Mathioudakis, Konstantinos
    Apalla, Zoe
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (12) : 1573 - 1581
  • [40] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
    Tencer, T.
    Xia, Q.
    Jobson, G.
    Qian, E.
    Dellon, E. S.
    VALUE IN HEALTH, 2022, 25 (07) : S432 - S432